NCT00600210 2017-08-23Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix CancerLeo W. Jenkins Cancer CenterPhase 2 Withdrawn